Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.

作者: Jiajia Li , Xiuling Zhi , Xiaoqing Shen , Chen Chen , Lei Yuan

DOI: 10.1016/J.BBRC.2019.12.058

关键词:

摘要: … Collectively, our findings strongly supported UBE2C as a candidate oncogene and a … UBE2C was involved in the development and progression of ovarian cancer, and targeting UBE2C …

参考文章(37)
Zhong Chen, Chunpeng Zhang, Dayong Wu, Hongyan Chen, Anna Rorick, Xiaoting Zhang, Qianben Wang, Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth The EMBO Journal. ,vol. 30, pp. 2405- 2419 ,(2011) , 10.1038/EMBOJ.2011.154
M T Berlingieri, P Pallante, M Guida, C Nappi, V Masciullo, G Scambia, A Ferraro, V Leone, A Sboner, M Barbareschi, A Ferro, G Troncone, A Fusco, UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas Oncogene. ,vol. 26, pp. 2136- 2140 ,(2007) , 10.1038/SJ.ONC.1210010
Pierlorenzo Pallante, Umberto Malapelle, Maria Teresa Berlingieri, Claudio Bellevicine, Romina Sepe, Antonella Federico, Danilo Rocco, Mario Galgani, Lorenzo Chiariotti, Montserrat Sanchez-Cespedes, Alfredo Fusco, Giancarlo Troncone, UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status European Journal of Cancer. ,vol. 49, pp. 1117- 1126 ,(2013) , 10.1016/J.EJCA.2012.09.033
Shang-Ze Li, Yang Song, Hui-Hui Zhang, Bing-Xue Jin, Yi Liu, Wen-Bin Liu, Xiao-Dong Zhang, Run-Lei Du, UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer Scientific Reports. ,vol. 4, pp. 6910- 6910 ,(2015) , 10.1038/SREP06910
Pierlorenzo Pallante, MT Berlingieri, Giancarlo Troncone, M Kruhoffer, TF Orntoft, G Viglietto, A Caleo, I Migliaccio, M Decaussin-Petrucci, M Santoro, L Palombini, A Fusco, None, UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. British Journal of Cancer. ,vol. 93, pp. 464- 471 ,(2005) , 10.1038/SJ.BJC.6602721
Akhilesh Rawat, Gopisetty Gopal, Ganesharaja Selvaluxmy, Thangarajan Rajkumar, Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole. Cellular Oncology. ,vol. 36, pp. 459- 467 ,(2013) , 10.1007/S13402-013-0150-8
Klaus W Wagner, Lisa M Sapinoso, Wa'el El-Rifai, Henry F Frierson, Nicole Butz, Juergen Mestan, Francesco Hofmann, Quinn L Deveraux, Garret M Hampton, Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin Oncogene. ,vol. 23, pp. 6621- 6629 ,(2004) , 10.1038/SJ.ONC.1207861
Chanlu Xie, Chris Powell, Mu Yao, Jianmin Wu, Qihan Dong, Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker The International Journal of Biochemistry & Cell Biology. ,vol. 47, pp. 113- 117 ,(2014) , 10.1016/J.BIOCEL.2013.11.023
Cheng Wang, Yun-Hao Pan, Ming Shan, Ming Xu, Jia-Lin Bao, Li-Ming Zhao, Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel International Journal of Molecular Sciences. ,vol. 16, pp. 4698- 4712 ,(2015) , 10.3390/IJMS16034698
Lei Jiang, Yi Bao, Chun Luo, Guohan Hu, Chengguang Huang, Xuehua Ding, Kehua Sun, Yicheng Lu, Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro. Journal of Cancer Research and Clinical Oncology. ,vol. 136, pp. 211- 217 ,(2010) , 10.1007/S00432-009-0651-Z